Here are eight headlines to know from dental supply company Henry Schein, as reported by Becker’s in 2025:
- Henry Schein recorded $881 million in U.S. dental sales in the third quarter of 2025.
- Henry Schein One is integrating Amazon Web Services’s generative AI technologies into Henry Schein’s dental programs.
- The company offered a $750 Million share repurchase plan.
- Oral Genome partnered with Henry Schein to expand the use of salivary testing in dental and medical offices.
- The company reported $872 million in U.S. dental sales in the second quarter of 2025, a 2.1% decrease from the second quarter of 2024.
- Stanley Bergman, CEO of Henry Schein, is stepping down from his position at the end of 2025.
- Henry Schein secured a $250 million strategic investment by global investment firm KKR.
- Henry Schein brought in $3.2 billion in total net sales during the first quarter of 2025.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
